Abstract:OBJECTIVE To validate ultrasonographic quantification and characterization criteria for aneurysms of the abdominal aorta (AAA) by comparing computed tomography data and surgical findings in order to standardize diagnosis and follow-up of AAA. PATIENTS AND METHODS A multicentric prospective study included 80 patients with AAA (January to August 1996). Standardized data on quantitative (diameter, surface area) and qualitative (topography, form, wall, thrombus) data were obtained at each ultrasound examination and at surgery. Ultrasound (US) and computed tomography (CT) explorations were performed and interpreted without prior knowledge by independent operators. US findings versus CT reference were compared in 77 cases, US findings versus surgical reference in 31, and CT findings versus surgery reference in 28. RESULTS Compared with CT-scan, B mode ultrasound (n = 77) underestimated the anteroposterior diameter of the aneurysm (mean difference -2.16 mm; p < 0.001), the anteroposterior diameters of the flow channel lumen (-5.54 mm; p < 0.001) and upper neck of the aneurysm (-2.74 mm; p < 0.001). Surface area measurements were not significantly different both the aneurysmal sac (p = 0.3) and the flow channel lumen (p = 1). Compared with surgical findings, US (n = 30) underestimated the transverse diameter (mean difference (-4.29 mm; p = 0.0037). Compared with surgery, US findings (n = 28) were not significantly different for the anteroposterior ans transverse diameters. Analyzing the form and wall of the AAA, US/CT-scan performance was good for symmetrical fusiform aneurysms (sensitivity 77%, specificity 67%). US and CT-scan were reliable for detecting wall bugles (same sensitivity, 29%). The angle formed by the thrombus with the wall (expressed in degrees) was not significantly different (p = 0.9). When the lower pole of the aneurysm was situated above the aortic bifurcation, US (sensitivity 75%) was more reliable than the CT-scan (sensitivity 50%) compared with surgical findings. CONCLUSION Ultrasonography should not be limited to the simple positive diagnosis of AAA. A precise analysis of the diameters and surface areas of the aneurysm should be performed.

Molecularly imprinted polymers with synthetic dummy templates for the preparation of capsaicin and dihydrocapsaicin from chili peppers.

Liquid biopsy for early diagnosis of non-small cell lung carcinoma: recent research and detection technologies

Liquid biopsy in lung cancer: significance in diagnostics, prediction, and treatment monitoring

Liquid biopsy techniques and lung cancer: diagnosis, monitoring and evaluation

Biomarkers of Lung Cancer: Liquid Biopsy Comes of Age

Liquid Biopsy for Lung Cancer: Up-to-Date and Perspectives for Screening Programs

Liquid Biopsies in Lung Cancer

Blood-based liquid biopsy: Insights into early detection and clinical management of lung cancer

The Liquid Biopsy for Lung Cancer: State of the Art, Limitations and Future Developments

Liquid Biopsy in Lung Cancer: Clinical Applications of Circulating Biomarkers (CTCs and ctDNA)

Current and future opportunities for liquid biopsy of circulating biomarkers to aid in early cancer detection

Liquid biopsy for human cancer: cancer screening, monitoring, and treatment

Liquid biopsies for cancer: From bench to clinic

The Role of Liquid Biopsy in Early Diagnosis of Lung Cancer

Liquid biopsy in cancer current: status, challenges and future prospects

[Advances in Liquid Biopsy and Its Clinical Application in the Diagnosis and Treatment of Non-small Cell Lung Cancer].

[Criteria for quantification and characterization of aneurysms of the abdominal aorta using ultrasonography. The AFFCA study. French Association of Continuous Education in Angiology].

Diagnostic and prognostic role of liquid biopsy in non-small cell lung cancer: evaluation of circulating biomarkers

Update on liquid biopsy in clinical management of non-small cell lung cancer

The three-hour conversation ratio: a test for hyperthyroidism.

Liquid biopsy in newly diagnosed patients with locoregional (I-IIIA) non-small cell lung cancer